Lee Chan-Mi, Jin Sang Woo, Jang Byunghyun, Ko Young Kyung, Gim Jeong-An
Department of Otorhinolaryngology-Head and Neck Surgery, Korea University Guro Hospital, Seoul, South Korea.
Department of Biomedical Sciences, College of Medicine, Korea University Guro Hospital, Seoul, South Korea.
Evol Bioinform Online. 2023 Aug 14;19:11769343231194020. doi: 10.1177/11769343231194020. eCollection 2023.
MicroRNAs (miRNAs) are a class of non-coding RNAs that act as regulators of disease. An evolutionary approach to the disease could reveal factors such as diagnosis, treatment, and prognosis prediction. The expression patterns of transposable element (TEs)-derived miRNAs could help elucidate diseases, and their evolutionary patterns are also valuable. The 34 miRNAs were compared in terms of stage survival and tumor status in 33 carcinomas from TCGA. Expression levels were compared using a -test and presented as differentially expressed miRNAs (DEMs). For DEMs showing statistically specific expression patterns for 3 conditions (normal and cancer, early and advanced stage, and survival), interactions with related genes in 10 species, including humans, were compared. The enrichment term was discovered for the gene-miRNA interactions. In 18 out of the 33 carcinomas, at least one miRNA was retrieved with < .05 and |fold change| >.05. A total of 128 DEMs for the 9 miRNAs were identified. Based on the TargetScan database, interactions between miRNAs and genes in 10 species, including humans, were confirmed. The evolutionarily conserved miR-130a was observed in all 10 species, whereas miR-151a was only observed in humans. GO terms of related genes were selected for the miRNAs commonly found in each species. Evolutionary analysis of TE-derived disease-associated miRNAs was performed, and the evolutionarily conserved miR-130a-related carcinomas included renal and thyroid cancers. Human and rhesus monkey-specific miR-625 is associated with various carcinomas.
微小RNA(miRNA)是一类作为疾病调节因子的非编码RNA。采用进化方法研究疾病可能会揭示诸如诊断、治疗和预后预测等因素。转座元件(TE)衍生的miRNA的表达模式有助于阐明疾病,其进化模式也具有重要价值。在来自癌症基因组图谱(TCGA)的33种癌症中,比较了34种miRNA在分期生存和肿瘤状态方面的情况。使用t检验比较表达水平,并将其呈现为差异表达的miRNA(DEM)。对于在三种条件(正常与癌症、早期与晚期以及生存)下显示出统计学上特定表达模式的DEM,比较了其与包括人类在内的10个物种中相关基因的相互作用。发现了基因-miRNA相互作用的富集术语。在33种癌症中的18种中,至少检索到一种miRNA,其P值<0.05且|倍数变化|>0.05。共鉴定出9种miRNA的128个DEM。基于TargetScan数据库,证实了包括人类在内的10个物种中miRNA与基因之间的相互作用。在所有10个物种中均观察到进化保守的miR-130a,而miR-151a仅在人类中观察到。针对每个物种中常见的miRNA选择了相关基因的基因本体(GO)术语。对TE衍生的疾病相关miRNA进行了进化分析,进化保守的miR-130a相关癌症包括肾癌和甲状腺癌。人类和恒河猴特有的miR-625与多种癌症相关。